RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs DPFunded

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

DPFD

DPFunded

DNA FUNDED

METRIC

DPFUNDED

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

80%

—

MAX FUNDING

$400,000

—

MIN COST

$58

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

DPFUNDED DETAILS

STEPS: 1-phase
DRAWDOWN: Fixed
MARKETS: Forex, Commodities, Indices

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

DPFunded PROS

+Steps to funded is 1, well below the industry average of 1.6, offering a faster route to capital.
+Min challenge cost of $58 is significantly below the industry average of $186.7, reducing upfront cost.
+Fixed drawdown type provides traders with clear and predictable risk boundaries.
+EA/automated trading is permitted, accommodating algorithmic and systematic trading strategies.

DPFunded CONS

−Overall drawdown of 6% is below the industry average of 7.9%, giving traders less room to absorb losses.
−Max funding of $400,000 is well below the industry average of $839,272.7, limiting earning potential.
−News trading is not allowed and payout frequency is monthly, restricting strategy flexibility and delaying income.

PROPDNA VERDICT

DNA Funded

Higher trust score (0/100). Faster payouts at —d.

START WITH DNAF